EX-99.1 2 a17-20943_1ex99d1.htm EX-99.1

Exhibit 99.1

 

 

PDMR Dealing

 

August 21, 2017, LONDON — Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces that, on August 17, 2017, Dr. David Ebsworth, Non-Executive Chairman of the Company, purchased 8,130 ordinary shares of 5 pence each in the Company (the “Ordinary Shares”) at a price of 122.5 pence per Ordinary Share.  Following the acquisition, Dr. Ebsworth will have an interest in the Company of 125,787 Ordinary Shares, representing 0.12% of the Company’s issued share capital.

 

The notification of dealing form can be found below.

 

For further information, please contact:

 

Verona Pharma plc

 

Tel: +44 (0)20 3283 4200

Jan-Anders Karlsson, Chief Executive Officer

 

info@veronapharma.com

 

 

 

N+1 Singer (Nominated Adviser and UK Broker)

 

Tel: +44 (0)20 7496 3000

Aubrey Powell / James White

 

 

 

 

 

FTI Consulting (UK Media and Investor enquiries)

 

Tel: +44 (0)20 3727 1000

Simon Conway / Natalie Garland-Collins

 

veronapharma@fticonsulting.com

 

 

 

ICR, Inc. (US Media and Investor enquiries)

 

 

Darcie Robinson

 

Tel: +1 203-682-8379
Darcie.Robinson@icrinc.com

Stephanie Carrington

 

Tel. +1 646-277-1282
Stephanie.Carrington@icrinc.com

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

 

 

a)

 

Name

 

David Ebsworth

 

 

 

 

 

2

 

Reason for the notification

 

 

 

a)

 

Position/status

 

Non-Executive Chairman

 

 

 

 

 

b)

 

Initial notification/Amendment

 

Initial notification

 


 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

 

a)

 

Name

 

Verona Pharma plc

 

 

 

 

 

b)

 

LEI

 

213800EVI6O6J3TIAL06

 

 

 

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

 

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares of 5 pence each


GB00BYW2KH80

 

 

 

 

 

b)

 

Nature of the transaction

 

David Ebsworth purchased 8,130 Ordinary Shares

 

 

 

 

 

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

 

 

 

 

122.5 pence per Ordinary Share

 

8,130 Ordinary Shares

 

 

 

 

 

 

 

d)

 

Aggregated information

 

N/A

 

 

 

 

 

 

 

·         Aggregated volume

 

 

 

 

 

 

 

 

 

·         Price

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

17 August 2017

 

 

 

 

 

f)

 

Place of the transaction

 

London Stock Exchange, AIM